Exhibit 10.2
FORM OF
SUBSCRIPTION
AGREEMENT
January 29, 2009
Pharmasset, Inc.
303-A College Road East
Princeton, NJ 08540
Ladies and Gentlemen:
The undersigned (the “
Investor ”), hereby confirms and agrees with
you as follows:
1. This Subscription Agreement (the
“ Agreement ”) is made as of the date
hereof between Pharmasset, Inc., a Delaware corporation (the
“ Company ”), and the
Investor.
2. The Company has authorized the
sale and issuance to certain investors of up to an aggregate of
4,678,000 shares (the “ Shares ”) of its
Common Stock, par value $0.001 per share (the “ Common
Stock ”), for a purchase price of $9.73 per share
(the “ Purchase Price ”). All defined
terms used herein and not otherwise defined shall have the same
meanings ascribed to such terms in the Placement Agency Agreement
dated the date hereof by and between Leerink Swann LLC (the “
Placement Agent ”) and the Company (the “
Placement Agency Agreement ”).
3. The offering and sale of the
Shares (the “ Offering ”) are being made
pursuant to (1) an effective Registration Statement on Form
S-3 (Registration No. 333-151749) (the “
Registration Statement ”) filed by the Company
with the Securities and Exchange Commission (the “
SEC ”), which contains the base prospectus (the
“ Base Prospectus ”) and was declared
effective by the SEC on June 26, 2008, (2) if applicable,
each “free writing prospectus” (as that term is defined
in Rule 405 under the Securities Act of 1933, as amended),
that has been or will be provided to the Investor on or prior to
the date hereof and (3) a final prospectus supplement (the
“ Prospectus Supplement ” and together
with the Base Prospectus, the “ Prospectus
”) containing certain supplemental information regarding the
Shares and terms of the Offering that will be filed with the SEC
and provided to the Investor along with the Company’s
counterpart to this Agreement or made available to the Investor by
the filing by the Company of an electronic version thereof with the
SEC. The Registration Statement, the documents incorporated by
reference therein and all free writing prospectuses are referred to
herein collectively as the “ Disclosure
Package. ”
4. The Company and the Investor
agree that the Investor will purchase from the Company, and the
Company will issue and sell to the Investor, the number of Shares
set forth below for the aggregate purchase price set forth below,
pursuant to and subject to the Terms and Conditions for Purchase of
Shares attached hereto as Annex I , which are incorporated
herein by reference as if fully set forth herein. Unless otherwise
requested by the Investor no later than one business day after the
execution of this Agreement by the Investor and agreed to by the
Company, the Shares purchased by the Investor will be delivered by
electronic book-entry at The Depository Trust Company (“
DTC ”), registered in the Investor’s name
and address as set forth below and will be released by
Computershare, the Company’s transfer
agent (the “ Transfer Agent ”), to the
Investor at the Closing (as defined in the Terms and Conditions for
Purchase of Shares). The Investor acknowledges that the Offering is
not being underwritten by the Placement Agent and that there is no
minimum offering amount. The Investor understands and agrees that
the Company, in its sole discretion, reserves the right to accept
or reject this subscription for Shares, in whole or in
part.
5. The Investor represents that,
except as set forth below, (a) it has had no position, office
or other material relationship within the past three years with the
Company or persons known to it to be affiliates of the Company,
(b) it is not, and as of the Closing will not be, a member of
FINRA or an Associated Person (as such term is defined under the
NASD Membership and Registration Rules Section 1011), and
(c) neither the Investor nor any group of Investors (as
identified in a public filing made with the SEC) of which the
Investor is a part in connection with the Offering of the Shares,
acquired, or obtained the right to acquire, 20% or more of the
Common Stock (or securities convertible into or exercisable for
Common Stock) or the voting power of the Company on a
post-transaction basis.
Exceptions:
(If no exceptions, write
“none.” If left blank, response will be deemed to be
“none.”)
6. The Investor confirms that it has
had full access to all filings made by the Company with the SEC,
including the Disclosure Package (as applicable), and that it was
able to read, review, download and print each such filing prior to
or in connection with the receipt of this Agreement along with the
Company’s counterpart to this Agreement. On or promptly
following the date hereof, the Company will file the Prospectus
Supplement with the SEC containing certain supplemental information
regarding the Company and the Offering.
[ Remainder of page intentionally
left blank. Signature pages follow .]
Number of Shares:
Aggregate Purchase Price: $
Please confirm that the foregoing
correctly sets forth the agreement between us by signing in the
space provided below for that purpose.
[ Signature Page to Subscription
Agreement ]
Agreed and accepted on January 29,
2009:
|
|
|
|
PHARMASSET,
INC.
|
|
|
|
By:
|
|
|
|
Name:
|
|
|
|
Title:
|
|
|
[ Signature Page to Subscription
Agreement ]
ANNEX I
TERMS AND CONDITIONS FOR PURCHASE OF
SHARES
1. Closings and Delivery of the
Shares and Funds.
1.1. Closing . The completion of the purchase and sale of the
Shares (the “ Closing ”) will occur at a
place and time (the “ Closing Date ”) to
be specified by the Company and the Placement Agent, and of which
the Investor will be notified in advance by the Placement Agent. At
the Closing, (a) the Company will cause the Transfer Agent to
deliver to the Investor the number of Shares set forth on the
signature page hereto registered in the name of the Investor or, if
so indicated on the Investor Questionnaire attached hereto as
Exhibit A , in the name of a nominee designated by the
Investor and (b) the aggregate purchase price for the Shares
being purchased by the Investor will be delivered by or on behalf
of the Investor to the Company.
1.2. Placement Agent Fee . The Investor acknowledges that the Company
intends to pay the Placement Agent a fee in respect of the sale of
Shares to the Investor.
1.3. Delivery of Funds . No later than one (1) business day
after the execution of this Agreement by the Investor and the
Company , the Investor shall remit by wire transfer the
amount of funds equal to the aggregate purchase price for the
Shares being purchased